Pharmagen, Inc. Share Price

Equities

Market Closed - OTC Markets Other stock markets 07:27:23 22/05/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2015	Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	CI
2014	Pharmagen, Inc. Announces Management Changes	CI

Duration

Period

Style

Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	30/15/30	CI
Pharmagen, Inc. Announces Management Changes	03/14/03	CI
Pharmagen, Inc. Announces Executive Changes	11/14/11	CI
Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer	11/14/11	CI
Pharmagen Appoints Additional Members to its Board of Directors	29/14/29	CI
Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales	06/14/06	CI
Pharmagen, Inc. Appoints Boyd Relac as Chief Operating Officer	29/14/29	CI
Pharmagen, Inc. announced that it has received $0.5 million in funding	01/14/01	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Member of Board of Directors and Interim-Chief Operating Officer	24/14/24	CI
Pharmagen, Inc. announced that it has received $0.15 million in funding.	24/14/24	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Chairman of the Board of Directors and Interim Chief Operating Officer	17/13/17	CI
Pharmagen, Inc. announced that it expects to receive $0.5 million in funding	12/13/12	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013	15/13/15	CI
Pharmagen Seeks Acquisitions	31/13/31	CI
Pharmagen, Inc. announced that it has received $0.04 million in funding from Asher Enterprises, Inc.	09/13/09	CI